Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 10 von 7653
Pharmacology & therapeutics (Oxford), 2018-04, Vol.184, p.189-200
2018
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
CYP-mediated drug metabolism in the brain impacts drug response
Ist Teil von
  • Pharmacology & therapeutics (Oxford), 2018-04, Vol.184, p.189-200
Ort / Verlag
England: Elsevier Inc
Erscheinungsjahr
2018
Quelle
Access via ScienceDirect (Elsevier)
Beschreibungen/Notizen
  • The functional role of cytochrome P450 (CYP) enzymes in the brain is an exciting and evolving field of research. CYPs are present and active in the brain, with heterogeneous patterns of expression, activity, and sensitivity to modulation across cell types, regions, and species. Despite total brain CYP expression being a fraction of hepatic CYP expression, the expanding literature of in vitro and in vivo experiments has provided evidence that brain CYPs can impact acute and chronic drug response, susceptibility to damage by neurotoxins, and are associated with altered personality, behaviour, and risk of neurological disease. They may also play a role in endogenous neurotransmitter and neurosteroid homeostasis. This review goes through the characterization of brain CYPs across species, the patterns of susceptibility of brain CYPs to exogenous induction, and recent preclinical evidence of the potential role of brain CYPs in vivo (e.g. CYP2D), along with the development of experiment paradigms that allow modulation of brain CYP activity without affecting CYP activity in the liver. Understanding brain CYP function, and changes therein, may provide unique strategies for the development of CNS-acting therapeutics metabolized locally in the brain, as well as therapeutics to target brain CYPs directly.
Sprache
Englisch
Identifikatoren
ISSN: 0163-7258
eISSN: 1879-016X
DOI: 10.1016/j.pharmthera.2017.10.008
Titel-ID: cdi_crossref_primary_10_1016_j_pharmthera_2017_10_008

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX